INDP
NASDAQ · Biotechnology
Indaptus Therapeutics Inc
$3.15
-0.06 (-1.87%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,194.3% upside
Low Target
$30.54
Average Target
$40.77
High Target
$54.50
Current Price
$3.15
Current
$3.15
$3.15
Target
$40.77
$40.77
$30.54
$40.77 avg
$54.50
Scenario Analysis
Bear Case
$30.54
869.5%
Low target
Base Case
$40.77
+1,194.3%
Avg target
Bull Case
$54.50
+1,630.2%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$5.96
-47.1% from high
52-Week Low
$0.92
+242.4% from low
Target vs 52W High
$40.77
+584.1% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.0% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |